{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T19:26:25Z","timestamp":1763580385735,"version":"3.40.5"},"reference-count":41,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain &amp; Palliative Care Pharmacotherapy"],"published-print":{"date-parts":[[2022,1,2]]},"DOI":"10.1080\/15360288.2022.2049422","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T18:24:57Z","timestamp":1647368697000},"page":"40-48","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Microinduction to Buprenorphine from Methadone for Chronic Pain: Outpatient Protocol with Case Examples"],"prefix":"10.1080","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4020-3449","authenticated-orcid":false,"given":"Marcelina","family":"Jasmine Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7957-6333","authenticated-orcid":false,"given":"Zhanette","family":"Coffee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8617-0761","authenticated-orcid":false,"given":"Jessica","family":"Goza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-7887","authenticated-orcid":false,"given":"Kelly","family":"Rumrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,3,15]]},"reference":[{"key":"CIT0001","unstructured":"Abuse NI on D. Prescription Opioids DrugFacts [Internet]. National Institute on Drug Abuse. 2020. https:\/\/www.drugabuse.gov\/publications\/drugfacts\/prescription-opioids. Accessed October 19, 2020."},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.22.2469"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1111\/1440-1681.13246"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-44022-4_41"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e31816b2f43"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2011\/14\/145"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2020.43386"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6501e1"},{"key":"CIT0009","first-page":"65","author":"Rudd RA.","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"355","key":"CIT0010","first-page":"8","volume":"2020","author":"Xu J.","year":"2018","journal-title":"NCHS Data Brief"},{"key":"CIT0011","unstructured":"Products \u2013 vital statistics rapid release \u2013 provisional drug overdose data [Internet]. 2021. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. Accessed June 15, 2021."},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.7326\/M17-0598"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06251-w"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.37765\/ajmc.2022.88785"},{"key":"CIT0015","unstructured":"Opioid Morphine EQ Conversion Factors (vFeb 2018).pdf [Internet]. https:\/\/www.hhs.gov\/guidance\/sites\/default\/files\/hhs-guidance-documents\/Opioid%20Morphine%20EQ%20Conversion%20Factors%20%28vFeb%202018%29.pdf. Accessed July 10, 2021."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(85)90002-5"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0929"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.04.020"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.06.030"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1982.tb39483.x"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-014-3723-y"},{"key":"CIT0022","unstructured":"TIP. Medications for opioid use disorder for healthcare and addiction professionals, policymakers, patients, and families. Treatment Improvement Protocol. 2021;63. https:\/\/store.samhsa.gov\/product\/TIP-63-Medications-for-Opioid-Use-Disorder-Full-Document\/PEP21-02-01-002. Accessed July 10, 2021."},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.71"},{"key":"CIT0024","unstructured":"SAMHSA. Buprenorphine quickstart guide [Internet]. https:\/\/www.samhsa.gov\/sites\/default\/files\/quick-start-guide.pdf. Accessed October 19, 2021."},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz197"},{"key":"CIT0026","unstructured":"Safety Information | Butrans\u00ae (buprenorphine) Transdermal System CIII [Internet]. https:\/\/butrans.com\/patient\/important-safety-information.html. Accessed July 10, 2021."},{"key":"CIT0027","unstructured":"belbuca-prescribing-info.pdf [Internet]. https:\/\/s3.amazonaws.com\/belbuca\/website\/pdfs\/belbuca-\u00adprescribing-info.pdf. Accessed October 19, 2021."},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S109919"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13135"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2011.00159.x"},{"key":"CIT0031","first-page":"pnab069","author":"Jasmine Silva M","year":"2021","journal-title":"Pain Med"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000623"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3182312983"},{"key":"CIT0034","unstructured":"McNicholas L. TIP 40: Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction: Treatment Improvement Protocol (TIP) Series. 40. Rockville (MD): U.S. Department of Health and Human Servies; 2004. p. 305."},{"key":"CIT0035","unstructured":"Center for Substance Abuse Treatment. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs. [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2005. [cited 2021 Oct 18]. (SAMHSA\/CSAT Treatment Improvement Protocols). http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK64164\/."},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2009.00005.x"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.12.014"},{"key":"CIT0038","unstructured":"sows_8-28-2017.pdf [Internet]. https:\/\/www.asam.org\/docs\/default-source\/education-docs\/sows_8-28-2017.pdf. Accessed July 13, 2021."},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00192-6"},{"key":"CIT0040","unstructured":"Prescribing Information | SUBOXONE\u00ae (buprenorphine and naloxone) Sublingual film (CIII). 33."},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2006.03.001"}],"container-title":["Journal of Pain &amp; Palliative Care Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/15360288.2022.2049422","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T13:57:01Z","timestamp":1651154221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/15360288.2022.2049422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,2]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,2]]}},"alternative-id":["10.1080\/15360288.2022.2049422"],"URL":"https:\/\/doi.org\/10.1080\/15360288.2022.2049422","relation":{},"ISSN":["1536-0288","1536-0539"],"issn-type":[{"type":"print","value":"1536-0288"},{"type":"electronic","value":"1536-0539"}],"subject":[],"published":{"date-parts":[[2022,1,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-15","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}